1. In Memoriam Elliot Rapaport

   • Lionel H. Opie

   OriginalPaper 24 February 2011 Pages: 1 - 1

   

2. Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes

   • Wei-Wen Hung
   • Tusty-Jiuan Hsieh
   • Shyi-Jang Shin

   OriginalPaper 15 December 2010 Pages: 3 - 12

   

3. Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats

   • Barbara Huisamen
   • Amanda Genis
   • Amanda Lochner

   OriginalPaper 19 November 2010 Pages: 13 - 20

   

4. AMP-Activated Protein Kinase Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells

   • Fang Jia
   • Chunfang Wu
   • Guoping Lu

   OriginalPaper 22 January 2011 Pages: 21 - 29

   

5. The Role of β-adrenergic Receptors in the Cardioprotective Effects of Beta-Preconditioning (βPC)

   • Ruduwaan Salie
   • Johannes A. Moolman
   • Amanda Lochner

   OriginalPaper 12 January 2011 Pages: 31 - 46

   

6. Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

   • Robert S. Rosenson
   • Dawn M. Carlson
   • Laura A. Williams

   OriginalPaper Open access 21 December 2010 Pages: 47 - 57

   

7. Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides

   • Christie M. Ballantyne
   • Peter H. Jones
   • James C. Stolzenbach

   OriginalPaper Open access 18 March 2011 Pages: 59 - 67

   

8. Clinical Trials Update AHA Congress 2010

   • John D. Horowitz
   • Robert S. Rosenson
   • Willem J. Remme

   OriginalPaper 22 February 2011 Pages: 69 - 76

9. Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)

   • Siobhan Gallanagh
   • Davide Castagno
   • John J. V. McMurray

   OriginalPaper 03 February 2011 Pages: 77 - 85

   

10. Rationale for Combining a Direct Renin Inhibitor with other Renin- Angiotensin System Blockers. Focus on Aliskiren and Combinations

    • Helmy M. Siragy

    OriginalPaper 07 January 2011 Pages: 87 - 97

    

11. Statins in Heart Failure—Where Do We Stand?

    • Kristopher S. Lyons
    • Gary E. McVeigh
    • Mark T. Harbinson

    OriginalPaper 07 December 2010 Pages: 99 - 104

12. Phosphatidylcholine-Rich Nanoliposomes: Potential Tools for Serum C-Reactive Protein Reduction?

    • Amirhossein Sahebkar

    Letter to the Editor 06 January 2011 Pages: 105 - 106

13. President’s Page

    • Juan-Carlos Kaski

    OriginalPaper 05 January 2011 Pages: 107 - 107